GLP-1 has an impact on various biological mechanisms, including improved insulin sensitivity, inhibition of glucagon synthesis, slowing gastric emptying [19], and reduced pancreatic cell apoptosis, when it signals through its specialized G protein-coupled receptor (GPCR), GLP-1R [20]
72,74 Additionally, endothelial activation plays a pivotal role in immunothrombosis and aberrant coagulation since elevated levels of endothelium-derived glycoproteins have been detected in ARDS patients with blood type A and are associated with an increased risk of disseminated intravascular coagulation
The goal is simple: use levocarnitine where it adds clarity and withdraw it when the risk-benefit ratio shifts
Your physician can also use a titration schedule to help make this decision
The clinical principle is start low and go slow. Your dose should escalate based on how you are tolerating it, not on a manufacturers pre-set schedule
JB, VS, MT, and LA: software